ストックスクリーナーアプリを入手
12.65
2.26%
0.28
前日終値:
$12.37
開ける：
$12.27
24時間の取引高:
2.74M
Relative Volume:
0.94
時価総額：
$1.80B
収益：
-
当期純損益:
$-412.89M
株価収益率:
-3.2772
EPS:
-3.86
ネットキャッシュフロー:
$-361.93M
1週間 パフォーマンス:
-4.09%
1か月 パフォーマンス:
-6.23%
6か月 パフォーマンス:
+20.94%
1年 パフォーマンス:
-64.78%
1日の値動き範囲:
$12.26
$12.83
1週間の範囲:
$11.92
$13.65
52週間の値動き範囲:
$6.36
$35.90
Dyne Therapeutics Inc Stock (DYN) Company Profile
DYN を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
DYN
Dyne Therapeutics Inc
|
12.65 | 1.76B | 0 | -412.89M | -361.93M | -3.86 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.64 | 101.35B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.00 | 58.66B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
562.27 | 59.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
737.56 | 44.01B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
340.70 | 36.56B | 3.81B | -644.79M | -669.77M | -6.24 |
Dyne Therapeutics Inc Stock (DYN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-08-25 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2025-06-24 | 開始されました | Bernstein | Mkt Perform |
| 2025-06-11 | 再開されました | Raymond James | Outperform |
| 2025-06-02 | 再開されました | Oppenheimer | Outperform |
| 2025-05-29 | 開始されました | Evercore ISI | Outperform |
| 2025-03-12 | 開始されました | BMO Capital Markets | Outperform |
| 2025-03-07 | 開始されました | Scotiabank | Sector Outperform |
| 2024-12-13 | 開始されました | Robert W. Baird | Outperform |
| 2024-11-26 | 開始されました | RBC Capital Mkts | Outperform |
| 2024-10-24 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2024-05-21 | 繰り返されました | Chardan Capital Markets | Buy |
| 2024-04-30 | 開始されました | Morgan Stanley | Overweight |
| 2024-02-20 | 開始されました | H.C. Wainwright | Buy |
| 2023-02-27 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2023-02-15 | 開始されました | Oppenheimer | Outperform |
| 2023-01-26 | 開始されました | Guggenheim | Buy |
| 2022-07-20 | 開始されました | Chardan Capital Markets | Buy |
| 2022-07-12 | 開始されました | Raymond James | Outperform |
| 2020-10-12 | 開始されました | JP Morgan | Overweight |
| 2020-10-12 | 開始されました | Jefferies | Buy |
| 2020-10-12 | 開始されました | Piper Sandler | Overweight |
| 2020-10-12 | 開始されました | Stifel | Buy |
すべてを表示
Dyne Therapeutics Inc (DYN) 最新ニュース
Applying big data sentiment scoring on Dyne Therapeutics Inc.2025 Market Sentiment & Short-Term High Return Ideas - newser.com
How Dyne Therapeutics Inc. stock performs in high volatility marketsJuly 2025 PostEarnings & Stepwise Swing Trade Plans - newser.com
Dyne Therapeutics, Inc. (DYN) Stock Analysis: 178.4% Potential Upside Sparks Investor Interest - DirectorsTalk Interviews
Technical signs of recovery in Dyne Therapeutics Inc.Options Play & Risk Controlled Stock Pick Alerts - newser.com
United States Myotonic Dystrophy Treatment Market Set for Rapid - openPR.com
Will Dyne Therapeutics Inc. stock keep outperforming rivalsTrade Risk Report & Daily Profit Maximizing Tips - newser.com
Dyne Therapeutics (NASDAQ:DYN) Stock Price Down 7.2%Here's Why - MarketBeat
Dyne Therapeutics (DYN) Gains Orphan Drug Status in Japan for Du - GuruFocus
Dyne Therapeutics Receives Orphan Drug Designation in Japan for DYNE-251 to Treat Duchenne Muscular Dystrophy - MarketScreener
Dyne Therapeutics receives orphan drug designation in Japan for DYNE-251 in Duchenne muscular dystrophy - MarketScreener
Dyne Therapeutics Receives Orphan Drug Designation in Japan for DYNE-251 in Duchenne Muscular Dystrophy - GlobeNewswire
Dyne Therapeutics Receives Orphan Drug Designation in Japan for DYNE-251 in Duchenne Muscular Dystrophy - Benzinga
Is Dyne Therapeutics Inc. stock a smart buy before Fed meeting2025 Price Momentum & High Return Stock Watch Alerts - newser.com
Will Dyne Therapeutics Inc. stock sustain high P E ratiosDollar Strength & Real-Time Market Trend Scan - newser.com
Published on: 2025-09-29 02:45:54 - newser.com
Applying Elliott Wave Theory to Dyne Therapeutics Inc.Swing Trade & Community Verified Trade Alerts - newser.com
Using Python tools to backtest Dyne Therapeutics Inc. strategiesJuly 2025 Pullbacks & Real-Time Chart Pattern Alerts - newser.com
What risks investors should watch in Dyne Therapeutics Inc. stockPortfolio Growth Summary & Long-Term Investment Growth Plans - newser.com
Can Dyne Therapeutics Inc. stock hit analyst price targetsWeekly Trend Report & Low Risk High Win Rate Stock Picks - newser.com
Voya Investment Management LLC Sells 200,017 Shares of Dyne Therapeutics, Inc. $DYN - MarketBeat
Aug Patterns: Is Dyne Therapeutics Inc on track to beat earningsJuly 2025 Update & Verified Chart Pattern Signals - خودرو بانک
Inflation Data: Can Dyne Therapeutics Inc disrupt its industryTake Profit & Fast Exit Strategy with Risk Control - khodrobank.com
Short Squeeze: Is Dyne Therapeutics Inc forming a double bottomJuly 2025 Movers & Growth Focused Stock Reports - خودرو بانک
Aug Action: Will Dyne Therapeutics Inc. benefit from government policyPortfolio Return Summary & AI Powered Buy and Sell Recommendations - khodrobank.com
First Week of November 21st Options Trading For Dyne Therapeutics (DYN) - Nasdaq
Can Dyne Therapeutics Inc. be recession proof2025 Geopolitical Influence & Long-Term Safe Investment Ideas - خودرو بانک
Signal Recap: Can Dyne Therapeutics Inc. ride the EV waveInflation Watch & Smart Allocation Stock Reports - khodrobank.com
Risk Off: Is Dyne Therapeutics Inc stock a smart retirement pickQuarterly Profit Review & Verified Momentum Stock Ideas - خودرو بانک
Will Dyne Therapeutics Inc. see short term momentumQuarterly Profit Review & Consistent Return Strategy Ideas - newser.com
Market Moves: Can Dyne Therapeutics Inc. expand its profit marginsDip Buying & Free High Return Stock Watch Alerts - خودرو بانک
Dyne Therapeutics (NASDAQ:DYN) Shares Down 3.7%Should You Sell? - MarketBeat
What to do if you’re stuck in Dyne Therapeutics Inc.July 2025 Review & Comprehensive Market Scan Reports - newser.com
Smart Money: Is Dyne Therapeutics Inc forming higher highs and higher lows2025 Technical Patterns & AI Powered Market Entry Strategies - خودرو بانک
Market Wrap: Is Dyne Therapeutics Inc being accumulated by smart moneyJuly 2025 Reactions & Community Trade Idea Sharing Platform - خودرو بانک
Market Overview: Will BlackRock Innovation and Growth Term Trust outperform small cap indexesJuly 2025 Setups & Advanced Technical Signal Analysis - خودرو بانک
Dyne Therapeutics Advances DMD Treatment with DYNE-251 Study - MSN
Rally Mode: Will Erasca Inc. benefit from AI trendsJuly 2025 Outlook & Risk Controlled Stock Pick Alerts - خودرو بانک
New Highs: Will Dyne Therapeutics Inc benefit from current market trendsMarket Growth Report & Risk Managed Investment Strategies - خودرو بانک
Risk vs reward if holding onto Dyne Therapeutics Inc.Buy Signal & Fast Gain Swing Alerts - newser.com
Voleon Capital Management LP Takes $624,000 Position in Dyne Therapeutics, Inc. $DYN - MarketBeat
Aug PreEarnings: Is Dyne Therapeutics Inc gaining market shareJuly 2025 Price Swings & Daily Market Momentum Tracking - خودرو بانک
Market Overview: Is Tactile Systems Technology Inc. being accumulated by smart moneyJuly 2025 Breakouts & Verified Momentum Watchlists - خودرو بانک
Visual trend scoring systems applied to Dyne Therapeutics Inc.Weekly Gains Summary & Daily Stock Trend Watchlist - newser.com
Breakout Move: Can Dyne Therapeutics Inc deliver consistent dividends2025 Key Lessons & Weekly Watchlist for Consistent Profits - خودرو بانک
Aug Highlights: Is Dyne Therapeutics Inc forming a double bottomWeekly Trade Report & Free Low Drawdown Momentum Trade Ideas - خودرو بانک
Is TOMI Environmental Solutions Inc.’s ROE strong enoughJuly 2025 Final Week & Fast Entry Momentum Trade Alerts - خودرو بانک
Is now a turning point for Dyne Therapeutics Inc.2025 Earnings Surprises & Entry Point Strategy Guides - newser.com
What hedge funds are buying Dyne Therapeutics Inc2025 Earnings Surprises & Risk Adjusted Buy and Sell Alerts - خودرو بانک
Exome Asset Management LLC Acquires Shares of 258,391 Dyne Therapeutics, Inc. $DYN - MarketBeat
John Cox Sells 2,640 Shares of Dyne Therapeutics (NASDAQ:DYN) Stock - MarketBeat
Exploring Dyne Therapeutics (DYN) Valuation After Recent Share Price Rebound - Yahoo Finance
Dyne Therapeutics Inc (DYN) 財務データ
収益
当期純利益
現金流量
EPS
2.36%
1.10%
大文字化:
|
ボリューム (24 時間):